- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate Hyperopia in South Africa
Total 99 results
-
Glaukos CorporationTerminatedHyperopia | Hyperopic AstigmatismUnited States
-
Microbiome Health Research InstituteUniversity of Cape TownTerminatedModerate Acute Malnutrition | Severe Acute MalnutritionSouth Africa
-
PfizerCompletedMild Hepatic Dysfunction | Moderate Hepatic DysfunctionSouth Africa
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Medical University of South CarolinaWithdrawnMyopia | HyperopiaUnited States
-
PfizerCompletedHealthy | Otherwise Healthy Volunteers With Mild or Moderate Hepatic DysfunctionUnited States
-
Bausch & Lomb IncorporatedRecruiting
-
Edwards LifesciencesRecruiting
-
Institut PasteurInstitut Pasteur de Madagascar; Action Contre la Faim; Centre de Recherches Médicales... and other collaboratorsCompletedModerate Acute MalnutritionCentral African Republic, Madagascar, Niger, Senegal
-
University Hospital Bispebjerg and FrederiksbergPopulation Health Research InstituteActive, not recruitingMyocardial Infarction | Myocardial Injury | HyperoxiaUnited States, China, Denmark, Malaysia, Canada, Colombia, India, South Africa
-
Advanced Vision CareClinical Research Consultants, Inc.Recruiting
-
PfizerTerminatedModerate-severe PainUnited States
-
University of SheffieldCompletedLong-term Physical Health Conditions | Mild to Moderate Anxiety and/or DepressionUnited Kingdom
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Women's and Children's Hospital, AustraliaAllergan Australia Pty LtdUnknown
-
Actinogen MedicalRecruitingAlzheimer Disease | Dementia, Mild | Dementia ModerateAustralia
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
Bristol-Myers SquibbTerminatedPsoriasis, Moderate to SevereUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Ralph H. Johnson VA Medical CenterJHSPH Center for Clinical TrialsNot yet recruitingBehavioral Symptoms | Agitation,Psychomotor | Dementia Moderate | Dementia SevereUnited States
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Janssen Research & Development, LLCRecruitingModerate Plaque PsoriasisUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Koneksa HealthCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
Debiopharm International SACompletedModerate Alzheimer's DiseaseAustralia, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
Medical University of South CarolinaEnrolling by invitation
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingBipolar Disorder | Cannabis Use | Bipolar I Disorder | Cannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe | Bipolar II Disorder | Schizoaffective Disorder, Bipolar TypeUnited States
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
Medical University of South CarolinaNational Institute of General Medical Sciences (NIGMS)Completed
-
Medical University of South CarolinaNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingParalysis | Spinal Cord Injuries | Spasticity, Muscle | Neurological InjuryUnited States
-
Medical University of South CarolinaNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingParalysis | Spinal Cord Injuries | Spasticity, Muscle | Neurological InjuryUnited States
-
Hoffmann-La RocheActive, not recruitingHemophilia A | Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor | Moderate Hereditary Factor VIII Deficiency Disease Without InhibitorUnited States, Netherlands, Belgium, France, Germany, South Africa, Spain, Canada, United Kingdom, Poland
-
BayerCompletedModerate Risk of CVDPoland, United States, Italy, United Kingdom, Germany, Spain, Puerto Rico, Ireland
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Genentech, Inc.TerminatedModerate-to-severe Allergic AsthmaUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisGermany